phase readout
saveNCT07476183: Assessing the Safety, Tolerability, and Efficacy of APR-2020 in Pediatric and Adolescent Subjects With RPS19 Deficient Diamond-Blackfan Anemia
RECRUITINGupdated 1d ago
community read0 votes
Sponsor: Apriligen, Inc.. Phase: PHASE1. Conditions: RPS19 Deficient Diamond-Blackfan Anemia
view source ↗
comments(0)
5-min edit window · permanent after that